I have to admit it...I am surprised by the low level of
I have to admit it...I am surprised by the low level of profit taking there has been after this relatively significant run. My guess is that whoever is holding from buying at recent lows still believes that the stock is way undervalued and is determined to hold most, if not all, for a while -- perhaps at least until after the PR of the N-Assay patent?
Considering how valuable the N-Assay patent is, I wonder if there are companies with deep pockets waiting to make an offer to buy the Company once the patent is formally issued. What may make it so much more valuable to potential suitors is that (according to my understanding) it is ELISA based, a decades old diagnostic test -- meaning that whoever acquires the patent can immediately begin to take market share without heavy expenditures on equipment, training, etc.
Btw, manipulators are still playing it cautious. Around 50% of shares traded today were due to shorting and on little volume. Some may argue that there was no buying interest. Meh. More probable that there is a shortage of sellers and that the buyers are patiently waiting for the manipulators to continue their games. My observation is that an attempt was made later in the day to paint the picture that sellers were starting to take profits, but it wasn't very convincing. I expect that they will continue to test the waters tomorrow. Maybe they dare to attack the bid aggressively?
Nanologix Inc (NNLX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Electra's Latest Win: A $4.7M USAF Experiment Forget your typical aviation story, folks. Electra Defense just scored a whopping $4.7 million contract from the U.S. Air Force Research Laboratory. The goal? To push the boundaries of hybrid-electric aircraft tech, specifically their Ultra-Short Takeoff and Landing (Ultra-STOL) capabilities. This isn't about pie-in-the-sky...
Continue Reading
Trimble Connect's Bold Move in AI In the relentless world of construction, where risk is as common as a hard hat, Trimble's rolling out some heavy-duty AI capabilities. Today, at the annual Trimble Dimensions bash in Las Vegas, the bigwigs at Trimble (NASDAQ:TRMB) flashed their latest trick: Trimble Connect's AI arsenal. It's not just a software upgrade; it's practically...
Continue Reading
A New Phase in Foam Blowing Agents You don’t come across a true leap in materials technology every day, and that’s exactly what's unfolding with Solstice Advanced Materials' latest venture. They’re not just talking the talk; they've hit a milestone in developing a next-gen foam blowing agent. This isn't just another tweak in a spreadsheet—it's a potential pivot in...
Continue Reading
Out in Silicon Valley, where innovation isn’t just a buzzword, the National Society of Autism Professionals (NSAP) is stirring the pot with some serious leadership moves. Just this month, they cobbled together their inaugural board of directors—a gathering of eight experts from every corner of the autism field you can think of. They’re not playing small ball, no...
Continue Reading
Finding Clarity Amid Chaos When life throws the unexpected, some folks crumble, but others, like Joyce L. Skala, sift through the rubble for clarity. Her debut memoir, "There's No Such Thing as Bad," weaves through personal chaos—embracing trauma and loss like a late-night poker game where the house always wins. Born from the charred memories of her family's home...
Continue Reading
Introduction to the Future of Solar Living Just when you thought you'd seen it all, along comes Outer Spaces with their OS1—a solar pavilion and battery deck that looks at residential energy with fresh eyes. Debuting at the RE+ 2026 in Las Vegas, this isn't just another gizmo. This is about bringing solar power to your backyard without making your roof look like it...
Continue Reading
Alfred Lomas' Transformation Fuels Lasting Change Once upon a time, Alfred Lomas was known as a brawler in the rough patches of South L.A., running with gangs and entangled in violence. But the story flipped, and instead of leaning into chaos, Lomas leaned into hope. That personal turnaround isn't just a headline—it's the crux behind Inner City Visions (ICV), the...
Continue Reading
CPT Changes: A New Era for Dermatology? Get this: the American Medical Association's revisions to the CPT codes could be just the spark LASEROPTEK's been waiting for. Landing on the desk is the 2027 Current Procedural Terminology (CPT) code set which clarifies how docs report targeted UVB laser treatments. We're talking about codes 96920–96922, now clear as crystal,...
Continue Reading
Revolution in Sleep Health The paper has officially announced a promising shift in sleep apnea treatment. Eli Lilly's Foundayo, revealed through a Phase 3 clinical program, is looking to tackle obstructive sleep apnea (OSA) with unprecedented potential. Forget the traditional methods—this small molecule GLP-1 receptor agonist could be a game changer for folks plagued by...
Continue Reading
Chipotle's BOGO Charade: A Tattooed Affair You've got to hand it to Chipotle—they know how to turn heads and wallets with their quirky promotions. The upcoming 'Tatted Like a Chipotle Bag' offer is a prime example of how they ride the cultural zeitgeist as they gear up for another record-breaking day on Friday, November 13. And seriously, with tattoos in play, they're...
Continue Reading
reading: EZ MOUSE Revolutionizes Multi-Device Computing Control">
Continue Reading